On August 14, the U.S. Department of Commerce’s Bureau of Industry and Security (BIS) announced a settlement with Plexon, Inc., a Texas neuroscience technology company. BIS asserts that Plexon exported neural recording systems to a restricted Chinese research institution without appropriate authorization under the U.S. Export Administration Regulations (EAR). The EAR is the set of regulations that control exports of U.S. dual-use items; BIS is the main government agency responsible for administering and enforcing the EAR.
| less than a minute read
BIS Settlement Highlights Export Control Risks for Medical and Research Technology

/Passle/68adf618fb5257a156b22ed3/SearchServiceImages/2026-11-18-14-13-10-258-6afdb276fe780fcb4c51df13.jpg)
/Passle/68adf618fb5257a156b22ed3/SearchServiceImages/2026-11-18-14-12-06-611-6afdb23653016789c4056cea.jpg)
/Passle/68adf618fb5257a156b22ed3/SearchServiceImages/2026-11-17-18-06-10-408-6afc9792452800fa09ad0765.jpg)
